I also just listened to the broadcast and, like you, agree that all shareholders need to listen to this.
It certainly put my mind at ease.
We know this works - the trials successfully met the endpoints.
The FDA is after a better understanding of some of the biomarkers that can be used to indicate it is working when administered to a patient.
It's a completely new field of treatment for them with many unknowns, but what we do know is that it works.
It was also mentioned that the COVID ARDS trial is providing a greater understanding in this area which gives me hope that we won't have the same problems with that request for approval.
I am confident that I will look back on this one day and be glad that I didn't panic.
Webcast Update, page-17
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |